Key Points
- CEO Dagi Shahar Ben-Noon purchased 168,894 shares of Inspira Technologies at an average price of $0.71, investing $119,914.74 and increasing his ownership by 4.86%.
- QTEX opened at $0.68, compared with a 52-week range of $0.28 to $3.85. The company reported a quarterly loss of $0.07 per share on $0.78 million in revenue.
- The board authorized a buyback of up to 5.6% of shares, but analyst sentiment remains negative: MarketBeat reports a consensus “Sell” rating.
Inspira Technologies OXY B.H.N. Ltd (NASDAQ:QTEX - Get Free Report) CEO Dagi Shahar Ben-Noon bought 168,894 shares of the stock in a transaction that occurred on Monday, September 28th. The stock was acquired at an average cost of $0.71 per share, for a total transaction of $119,914.74. Following the purchase, the chief executive officer owned 3,646,133 shares of the company's stock, valued at $2,588,754.43. This trade represents a 4.86% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
Inspira Technologies OXY B.H.N. Stock Performance
NASDAQ QTEX opened at $0.68 on Wednesday. The stock's 50 day simple moving average is $0.88. Inspira Technologies OXY B.H.N. Ltd has a one year low of $0.28 and a one year high of $3.85. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.62 and a current ratio of 2.00.
Inspira Technologies OXY B.H.N. (NASDAQ:QTEX - Get Free Report) last issued its quarterly earnings data on Thursday, September 24th. The company reported ($0.07) earnings per share (EPS) for the quarter. The business had revenue of $0.78 million during the quarter.
Inspira Technologies OXY B.H.N. declared that its board has initiated a share buyback plan on Monday, June 22nd that allows the company to repurchase 2,000,000,000,000 shares. This repurchase authorization allows the company to purchase up to 5.6% of its shares through open market purchases. Shares repurchase plans are typically a sign that the company's leadership believes its stock is undervalued.
Wall Street Analyst Weigh In
A number of equities research analysts have commented on QTEX shares. Wall Street Zen lowered shares of Inspira Technologies OXY B.H.N. from a "hold" rating to a "sell" rating in a report on Saturday, August 8th. Weiss Ratings raised shares of Inspira Technologies OXY B.H.N. from a "sell (e+)" rating to a "sell (d-)" rating in a research note on Friday. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock has a consensus rating of "Sell".
View Our Latest Report on QTEX
Inspira Technologies OXY B.H.N. Company Profile
(
Get Free Report)
Inspira Technologies OXY B.H.N. Ltd. is an Israeli medical technology company focused on developing advanced respiratory-support systems for patients experiencing acute respiratory failure. The company's technology is intended to support blood oxygenation and carbon-dioxide removal while potentially reducing reliance on invasive mechanical ventilation.
Its principal product platform is the INSPIRA ART system, an extracorporeal respiratory-support technology designed to oxygenate blood outside the body and return it to the patient.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
